Literature DB >> 34481733

Terpenoid treatment in osteoporosis: this is where we have come in research.

Daniele Bellavia1, Fabio Caradonna2, Eufrosina Dimarco2, Viviana Costa3, Valeria Carina3, Angela De Luca3, Lavinia Raimondi3, Carla Gentile2, Riccardo Alessandro4, Milena Fini3, Gianluca Giavaresi3.   

Abstract

Lower bone resistance to load is due to the imbalance of bone homeostasis, where excessive bone resorption, compared with bone formation, determines a progressive osteopenia, leading to a high risk of fractures and consequent pain and functional limitations. Terpenoids, with their activities against bone resorption, have recently received increased attention from researchers. They are potentially more suitable for long-term use compared with traditional therapeutics. In this review of the literature of the past 5 years, we provide comprehensive information on terpenoids, with their anti-osteoporotic effects, highlighting molecular mechanisms that are often in epigenetic key and a possible pharmacological use in osteoporosis prevention and treatment.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  bone erosive diseases; osteoblast; osteoclast; osteoporosis; terpenoids

Mesh:

Substances:

Year:  2021        PMID: 34481733     DOI: 10.1016/j.tem.2021.07.011

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  3 in total

Review 1.  Evolving Roles of Natural Terpenoids From Traditional Chinese Medicine in the Treatment of Osteoporosis.

Authors:  Yue Zhuo; Meng Li; Qiyao Jiang; Hanzhong Ke; Qingchun Liang; Ling-Feng Zeng; Jiansong Fang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-16       Impact factor: 6.055

2.  Gut Metabolite Urolithin A Inhibits Osteoclastogenesis and Senile Osteoporosis by Enhancing the Autophagy Capacity of Bone Marrow Macrophages.

Authors:  Huaqiang Tao; Yunxia Tao; Chen Yang; Wenming Li; Wei Zhang; Xueyan Li; Ye Gu; Yujing Hong; Huilin Yang; Yu Liu; Xing Yang; Dechun Geng
Journal:  Front Pharmacol       Date:  2022-05-12       Impact factor: 5.988

3.  Network pharmacology of iridoid glycosides from Eucommia ulmoides Oliver against osteoporosis.

Authors:  Ting Wang; Liming Fan; Shuai Feng; Xinli Ding; Xinxin An; Jiahuan Chen; Minjuan Wang; Xifeng Zhai; Yang Li
Journal:  Sci Rep       Date:  2022-05-06       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.